🚀 Gate Square “Gate Fun Token Challenge” is Live!
Create tokens, engage, and earn — including trading fee rebates, graduation bonuses, and a $1,000 prize pool!
Join Now 👉 https://www.gate.com/campaigns/3145
💡 How to Participate:
1️⃣ Create Tokens: One-click token launch in [Square - Post]. Promote, grow your community, and earn rewards.
2️⃣ Engage: Post, like, comment, and share in token community to earn!
📦 Rewards Overview:
Creator Graduation Bonus: 50 GT
Trading Fee Rebate: The more trades, the more you earn
Token Creator Pool: Up to $50 USDT per user + $5 USDT for the first 50 launche
Carbios price target (EPA:ALCRB) increases by 14.20% to 60.57
The one-year average price target for Carbios has been revised to 60.57 per share, representing a 14.20% increase from the previous estimate of 53.04 on June 1, 2023.
This target is an average of several projections provided by analysts. The latest targets range from a minimum of 54.73 to a maximum of 71.83 per share. The average target price represents an increase of 90.77% from the last reported closing price of 31.75 per share.
I find it interesting that while analysts are showing optimism, the sentiment of investment funds does not reflect the same enthusiasm. There has been a 25% decrease in the number of institutional owners in the last quarter. Shares held by institutions have drastically fallen by 90.92%, leaving only 11,000 shares.
The average portfolio allocation for ALCRB is 0.01%, with an increase of 18.74%. This suggests that although fewer institutions are maintaining positions, those that remain are slightly increasing their exposure.
Among the most notable shareholders, one holds 6,000 shares (, 0.05% ownership ) unchanged in the last quarter. Another owns 5,000 shares ( also 0.05% ), having reported a slight decrease of 0.44% but increasing their portfolio allocation by 1.36%.
The disparity between analysts' optimism and institutional caution makes me question whether there are really solid fundamentals for this upward revision. Are analysts seeing something that institutional investors do not see, or are they simply being too optimistic?